![Mark Lampert](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Lampert
Chief Executive Officer at
BVF, Inc.
Profile
Mr. Mark N.
Lampert is a Chief Executive Officer at BVF Partners LP, a Chief Executive & Financial Officer & Secretary at BVF, Inc. and a President at BVF Partners OS Ltd. He is on the Board of Directors at AvMax, Inc. and Mendel Biotechnology, Inc.
Mr. Lampert was previously employed as a Head-Business Development by Cambridge NeuroScience, Inc., a Non-Executive Director by Biotica Technology Ltd., a Vice President by Oppenheimer & Co., Inc., and a Principal by The Boston Consulting Group, Inc. He also served on the board at CASCADIAN THERAPEUTICS INC, Acumen Pharmaceuticals, Inc., Athersys, Inc. /Old/ and Ziarco Pharma Ltd.
He received his undergraduate degree from Harvard College and an MBA from Harvard Business School.
Mark Lampert active positions
| Companies | Position | Start |
|---|---|---|
BVF, Inc.
 BVF, Inc. Investment Banks/BrokersFinance Manages hedge funds and engages in investment business | Chief Executive Officer | 14/09/1993 |
AvMax, Inc.
 AvMax, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Director/Board Member | - |
Mendel Biotechnology, Inc.
 Mendel Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Develops genetic and chemical solutions for the agricultural markets | Director/Board Member | - |
BVF Partners LP
 BVF Partners LP Investment ManagersFinance BVF generally pursues value-oriented investment strategies, investing primarily in the marketable securities issued by biotechnology companies. The focus of the BVF strategy is on fundamental, bottom-up analysis of individual issuers based on the theory that market mispricing exist because market prices do not incorporate all knowable economic and other relevant data. | Chief Executive Officer | 01/11/1993 |
BVF Partners OS Ltd.
 BVF Partners OS Ltd. Real Estate DevelopmentFinance Provides real estate services | President | - |
Former positions of Mark Lampert
| Companies | Position | End |
|---|---|---|
| CASCADIAN THERAPEUTICS INC (USA) | Director/Board Member | 17/01/2017 |
Biotica Technology Ltd.
 Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Director/Board Member | 12/03/2013 |
CeNeS Pharmaceuticals, Inc.
 CeNeS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops pharmaceuticals focusing on nerve cell survival & function | Corporate Officer/Principal | 31/12/1989 |
Ziarco Pharma Ltd.
 Ziarco Pharma Ltd. BiotechnologyHealth Technology Provides therapeutics targeting inflammatory and allergic diseases | Director/Board Member | - |
| ░░░░░░░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Mark Lampert
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
20
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
CeNeS Pharmaceuticals, Inc.
CeNeS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops pharmaceuticals focusing on nerve cell survival & function | Health Technology |
BVF, Inc.
BVF, Inc. Investment Banks/BrokersFinance Manages hedge funds and engages in investment business | Finance |
BVF Partners LP
BVF Partners LP Investment ManagersFinance BVF generally pursues value-oriented investment strategies, investing primarily in the marketable securities issued by biotechnology companies. The focus of the BVF strategy is on fundamental, bottom-up analysis of individual issuers based on the theory that market mispricing exist because market prices do not incorporate all knowable economic and other relevant data. | Finance |
Oppenheimer & Co., Inc.
 Oppenheimer & Co., Inc. Investment ManagersFinance Provides wealth and asset management, brokerage & investment banking services | Finance |
Athersys, Inc. /Old/
 Athersys, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutic biological products | Health Technology |
Acumen Pharmaceuticals, Inc.
 Acumen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops medicines and diagnostics for Alzheimer's disease | Health Technology |
Biotica Technology Ltd.
Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Mendel Biotechnology, Inc.
Mendel Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Develops genetic and chemical solutions for the agricultural markets | Commercial Services |
AvMax, Inc.
AvMax, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Ziarco Pharma Ltd.
Ziarco Pharma Ltd. BiotechnologyHealth Technology Provides therapeutics targeting inflammatory and allergic diseases | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BVF Partners OS Ltd.
BVF Partners OS Ltd. Real Estate DevelopmentFinance Provides real estate services | Finance |
- Stock Market
- Insiders
- Mark Lampert
Choose MarketScreener 
